Portfolio company
Nanordica Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
3 investors
Sectors
About
This deep-tech company develops antibacterial nanotechnology wound dressings to treat chronic and infected wounds for patients with diabetic foot ulcers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
EsaDres
The company develops personalised wound dressings using electrospinning technology for patients in hospitals to improve healing and reduce infection risks.
Plasmacure
This company develops cold plasma medical devices for healthcare professionals to treat chronic wounds such as diabetic foot ulcers and pressure sores.
DEBx Medical
This company develops chemical debridement agents for healthcare professionals to treat chronic wounds by removing infection and biofilm.
Piomic
The company develops a portable device using optical and magnetic stimulation to treat chronic wounds for patients in clinical and homecare settings.
Amferia
This company produces antimicrobial hydrogel wound dressings for human healthcare and veterinary markets to combat antibiotic-resistant bacterial infections.
Besthealth4u
This company develops bio-based medical adhesives and wearable sensor patches for wound care and medical device manufacturers to prevent skin injuries and monitor healing.
Bluedrop Medical
This company develops a remote monitoring scale that scans feet to detect early signs of ulcers for patients living with diabetes.
Secuped
Secuped develops a home monitoring device that measures foot temperatures to help diabetic patients and clinicians detect and prevent ulcers.
